Real-time PCR for research in the detection of sexually transmitted infections.
Optimize your STI research testing with a reliable, accurate, and sensitive molecular solution
The global prevalence of sexually transmitted infections (STIs) is measured at more than 1 million new cases every day, most of which are asymptomatic. Accordingly, there are approximately 374 million new infections each year, which include three of the most common curable STIs: chlamydia, gonorrhea, and
trichomoniasis . These three STIs, as well as the bacterium Mycoplasma genitalium, can lead to complications including cervicitis, urethritis, preterm labor, and pelvic inflammatory
disease (PID). They can also increase the risk of contracting HIV.
This makes the detection of common prevalent STIs important for clinical researchers to understand outbreaks and disease etiology
The Applied Biosystems™ TrueMark™ STI Select Panel employs real-time PCR technology, offering an end-to-end workflow for the detection of common STIs by utilizing the power of Applied Biosystems™ QuantStudio™ real-time PCR
The TrueMark STI Select Panel includes multiplexed assays in a single-tube format to detect Chlamydia trachomatis, Neisseria
gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis, as well as internal process control, in the same reaction. QuantStudio real-time PCR systems enable rapid, accurate detection and categorization of these microorganisms
that cause four common STIs.
Features of the TrueMark STI Select Panel
TrueMark STI Select Panel workflow
Utilize an end-to-end workflow to expand your molecular infectious disease research menu
The TrueMark STI Select Panel features a single-tube multiplexed assay option, including four STI targets and an internal process control, and is optimized for use on QuantStudio qPCR systems.
Go from sample to result in approximately 4 hours.
TrueMark STI Select Panel